tripelennamine has been researched along with Neonatal Abstinence Syndrome in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schnoll, SH | 1 |
| Chasnoff, IJ | 1 |
| Glassroth, J | 1 |
1 other study available for tripelennamine and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
Pentazocine and tripelennamine abuse: T's and Blues.
Topics: Adult; Female; Humans; Infant, Newborn; Lung Diseases, Obstructive; Lung Volume Measurements; Male; | 1985 |